Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nersting

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|December 21, 2021
Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort studyLine Hjøllund Pedersen, Anna Østergaard, Victoria Bank, et al.
Haematologica|February 17, 2018
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemiaNikki A Evensen, P Pallavi Madhusoodhan, Julia Meyer, et al.
International Journal of Cancer|March 3, 2020
Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiotaSilvia De Pietri, Anna C Ingham, Thomas L Frandsen, et al.
Inflammatory Bowel Diseases|August 31, 2021
Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNAAnne Grosen, Emanuelle Bellaguarda, Jacob Nersting, et al.
Pediatric Blood & Cancer|April 20, 2017
Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolitesLinea Natalie Toksvang, Silvia De Pietri, Stine N Nielsen, et al.
Oncoimmunology|December 22, 2022
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockadeLoulieta Nazerai, Shona Caroline Willis, Patricio Yankilevich, et al.
Pediatric Blood & Cancer|January 8, 2014
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancerMette Levinsen, Elisabeth Ørskov Rotevatn, Susanne Rosthøj, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemiaMathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen, et al.
Haematologica|May 28, 2021
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemiaRikke Hebo Larsen, Cecilie Utke Rank, Kathrine Grell, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2021
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyLinea Natalie Toksvang, Liv Andrés-Jensen, Cecilie Utke Rank, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|December 21, 2021
Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort studyLine Hjøllund Pedersen, Anna Østergaard, Victoria Bank, et al.
Haematologica|February 17, 2018
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemiaNikki A Evensen, P Pallavi Madhusoodhan, Julia Meyer, et al.
International Journal of Cancer|March 3, 2020
Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiotaSilvia De Pietri, Anna C Ingham, Thomas L Frandsen, et al.
Inflammatory Bowel Diseases|August 31, 2021
Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNAAnne Grosen, Emanuelle Bellaguarda, Jacob Nersting, et al.
Pediatric Blood & Cancer|April 20, 2017
Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolitesLinea Natalie Toksvang, Silvia De Pietri, Stine N Nielsen, et al.
Oncoimmunology|December 22, 2022
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockadeLoulieta Nazerai, Shona Caroline Willis, Patricio Yankilevich, et al.
Pediatric Blood & Cancer|January 8, 2014
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancerMette Levinsen, Elisabeth Ørskov Rotevatn, Susanne Rosthøj, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemiaMathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen, et al.
Haematologica|May 28, 2021
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemiaRikke Hebo Larsen, Cecilie Utke Rank, Kathrine Grell, et al.
Cancer Chemotherapy and Pharmacology|June 19, 2021
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-studyLinea Natalie Toksvang, Liv Andrés-Jensen, Cecilie Utke Rank, et al.
Pageof 5